Promising GBS drug trial pulled before it began
Disease control
Terminated
This study aimed to test the safety and effectiveness of efgartigimod in people with Guillain-Barre syndrome (GBS), a rare nerve disorder causing muscle weakness. Participants would have received the drug alongside standard care and undergone blood tests to measure nerve damage. …
Phase: PHASE2 • Sponsor: Chafic Karam • Aim: Disease control
Last updated May 26, 2026 12:07 UTC